<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T05:14:28Z</responseDate>
  <request identifier="oai:figshare.com:article/34057653" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34057653</identifier>
        <datestamp>2026-10-02T18:08:53Z</datestamp>
        <setSpec>category_1</setSpec>
        <setSpec>category_4</setSpec>
        <setSpec>category_7</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_15</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>portal_63</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Three Distinct
Binding Modes Govern High-Affinity
Ligand Interactions with Amyloid Fibrils</dc:title>
          <dc:creator>Timothy S. Chisholm (19226586)</dc:creator>
          <dc:subject>Biophysics</dc:subject>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Neuroscience</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>three distinct high</dc:subject>
          <dc:subject>represent attractive biomarkers</dc:subject>
          <dc:subject>characteristic fluorescence responses</dc:subject>
          <dc:subject>affinity ligand interactions</dc:subject>
          <dc:subject>binding ligand scaffolds</dc:subject>
          <dc:subject>analyze binding behavior</dc:subject>
          <dc:subject>affinity binding modes</dc:subject>
          <dc:subject>binding modes</dc:subject>
          <dc:subject>interacting binding</dc:subject>
          <dc:subject>binding mode</dc:subject>
          <dc:subject>binding ligands</dc:subject>
          <dc:subject>work outlines</dc:subject>
          <dc:subject>therapeutic targets</dc:subject>
          <dc:subject>practical framework</dc:subject>
          <dc:subject>poor understanding</dc:subject>
          <dc:subject>neurodegenerative diseases</dc:subject>
          <dc:subject>mathematical framework</dc:subject>
          <dc:subject>future fibril</dc:subject>
          <dc:subject>findings establish</dc:subject>
          <dc:subject>experimental approach</dc:subject>
          <dc:subject>defining feature</dc:subject>
          <dc:subject>amyloid fibrils</dc:subject>
          <dc:description>Fibrillar protein
aggregates are a defining feature of neurodegenerative
diseases and represent attractive biomarkers and therapeutic targets.
However, the rational design of small-molecule ligands and probes
targeting these aggregates is limited by a poor understanding of how
ligands bind to amyloid fibrils. This work outlines an experimental
approach to determine the binding mode of ligands to amyloid fibrils
using previously overlooked information contained within standard
binding assays. Using a mathematical framework to analyze binding
behavior, three distinct high-affinity binding modes were identified:
discrete, overlapping, and interacting binding. Reanalysis of published
binding data indicates that these binding modes are widespread among
common amyloid-binding ligand scaffolds. Two ligands were designed
using
principles informed by these binding modes, yielding improved binding
affinities and characteristic fluorescence responses. These findings
establish a practical framework for determining how small molecules
bind amyloid fibrils using straightforward binding assays and for
guiding the design of future fibril-binding ligands and probes.</dc:description>
          <dc:date>2026-10-02T00:00:00Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1021/acs.biochem.6c00489.s002</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Three_Distinct_Binding_Modes_Govern_High-Affinity_Ligand_Interactions_with_Amyloid_Fibrils/34057653</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
